Myoclonus: Clinical Trials

3 trials for Myoclonus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1

Follow Myoclonus: new trials by email Literature Review of Myoclonus trials Research Report on Myoclonus

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
Ambroxol - Gaucher Disease, Type 3
Not applicableCompletedAgyany Pharma LTD122025-03-012026-08-24
Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection
Remifentanil - Etomidate, Myoclonus
Not applicableUnknownYangzhou University702023-03-012023-03-06
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
DystoniaNet-based diagnosis of isolated dystonia - Dystonia, Drug Induced Dystonia
Not applicableRecruitingMassachusetts Eye and Ear Infirmary10002022-06-012025-12-02

Narrower conditions

Ataxia (1)  ·  Dyskinesias (1)  ·  Dysphonia (1)  ·  Dystonia (1)  ·  Essential Tremor (1)  ·  Gaucher Disease (1)  ·  Lysosomal Storage Diseases (1)  ·  Neurologic Manifestations (1)  ·  Parkinson Disease (1)  ·  Temporomandibular Joint Disorders (1)  ·  Tic Disorders (1)  ·  Torticollis (1)  ·  Ulnar Nerve Compression Syndromes (1)

Broader conditions

Nervous System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Dyskinesias (2)  ·  Neurologic Manifestations (2)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniomandibular Disorders (1)  ·  Cumulative Trauma Disorders (1)  ·  Genetic Diseases, Inborn (1)  ·  Jaw Diseases (1)

Interventions

Ambroxol (1)  ·  Remifentanil (1)

Sponsors

Agyany Pharma LTD (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Yangzhou University (1)

Countries

Pakistan (1)  ·  United States (1)

Top investigators

Huma Arshad Cheema, Prof. (1)  ·  Kristina Simonyan, MD, PhD (1)